Ameriprise’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,944
| Closed | -$251K | – | 4002 |
|
|
2024
Q4 | $251K | Buy |
+9,944
| New | +$251K | ﹤0.01% | 3757 |
|
|
2018
Q2 | – | Sell |
-512,961
| Closed | -$17.9M | – | 3633 |
|
|
2018
Q1 | $17.9M | Buy |
512,961
+479,589
| +1,437% | +$16.8M | 0.01% | 1203 |
|
|
2017
Q4 | $1.42M | Buy |
33,372
+3,945
| +13% | +$168K | ﹤0.01% | 2831 |
|
|
2017
Q3 | $1.26M | Buy |
29,427
+3,975
| +16% | +$171K | ﹤0.01% | 2858 |
|
|
2017
Q2 | $943K | Buy |
+25,452
| New | +$943K | ﹤0.01% | 2966 |
|
|
2016
Q1 | – | Sell |
-16,185
| Closed | -$3.81M | – | 3745 |
|
|
2015
Q4 | $3.81M | Buy |
16,185
+1,538
| +11% | +$362K | ﹤0.01% | 2218 |
|
|
2015
Q3 | $2.32M | Sell |
14,647
-5,837
| -28% | -$923K | ﹤0.01% | 2526 |
|
|
2015
Q2 | $7.75M | Buy |
20,484
+4,213
| +26% | +$1.59M | ﹤0.01% | 1802 |
|
|
2015
Q1 | $6.8M | Buy |
16,271
+10,581
| +186% | +$4.42M | ﹤0.01% | 1889 |
|
|
2014
Q4 | $1.56M | Buy |
5,690
+2,576
| +83% | +$705K | ﹤0.01% | 2664 |
|
|
2014
Q3 | $605K | Sell |
3,114
-761
| -20% | -$148K | ﹤0.01% | 2982 |
|
|
2014
Q2 | $948K | Sell |
3,875
-19,844
| -84% | -$4.85M | ﹤0.01% | 2793 |
|
|
2014
Q1 | $6.29M | Sell |
23,719
-14,543
| -38% | -$3.86M | ﹤0.01% | 1867 |
|
|
2013
Q4 | $13.9M | Buy |
38,262
+11,938
| +45% | +$4.34M | 0.01% | 1262 |
|
|
2013
Q3 | $14M | Buy |
26,324
+21,108
| +405% | +$11.2M | 0.01% | 1236 |
|
|
2013
Q2 | $1.22M | Buy |
+5,216
| New | +$1.22M | ﹤0.01% | 2546 |
|